BSE
Your Result on : Company News Details
Emcure Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
544210
ISIN Demat
INE168P01015
Book Value (Rs)
216.4487187
NSE Symbol
EMCURE
Divident Yield %
0.15
Market Cap
(Rs In Cr.)
44,378
P/E (TTM)
46.29
EPS (TTM)
50.53
Face Value
(Rs)
10
Back
Emcure Pharmaceuticals consolidated net profit rises 33.73% in the September 2026 quarter
03-Nov-26   Hrs IST

Net profit of Emcure Pharmaceuticals rose 33.73% to Rs 325.57 crore in the quarter ended September 2026 as against Rs 243.46 crore during the previous quarter ended September 2025. Sales rose 24.26% to Rs 2820.47 crore in the quarter ended September 2026 as against Rs 2269.82 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales2820.472269.82 24
OPM %20.8420.95 -
PBDT555.52446.06 25
PBT445.85341.42 31
NP325.57243.46 34

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
BSE Delayed market data sourced at 5 minutes – www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)